Who Can Participate
You may be able to participate in the dreaMM8 study if:
- You are at least 18 years old.
- You are diagnosed with multiple myeloma.
- You have been previously treated with at least one prior line of multiple myeloma therapy including a lenalidomide-containing regimen. (Lenalidomide must have been administered for at least 2 consecutive cycles.)
- Your multiple myeloma progressed (got worse) during or after your most recent therapy.
There are other eligibility requirements that the study doctor will review with you.
Answer a few questions to see if you may qualify for the dreaMM8 study.